Digital Ayurveda–Based Integrative Oncology for Prevention of Throat Tumor Recurrence: A Digitally Monitored Observational Clinical Study

Abstract

Background: Recurrence of throat tumors continues to pose a major challenge in head and neck oncology despite significant advances in surgery, radiotherapy, and chemotherapy. Survivorship care now emphasizes integrative and digitally supported approaches to improve immune resilience, reduce oxidative stress, and enhance quality of life. Ayurveda, through Rasayana Chikitsa, offers a rejuvenative framework that aligns with modern integrative oncology principles¹,²,³.

Objective: This study aimed to evaluate the effectiveness of a digitally monitored Rasayana-based integrative oncology model in reducing recurrence risk and improving survivorship outcomes in patients treated for throat tumors.

Methods: An open-label observational study was conducted on thirty post-treatment throat tumor patients. Participants were divided into a Rasayana-integrative group receiving Ayurvedic Rasayana therapy with digital follow-up and a control group receiving standard oncological care alone. Clinical recurrence, immunological parameters, antioxidant status, and quality of life (WHOQOL-BREF) were assessed over six months⁴.

Results: The Rasayana-integrative group demonstrated a lower recurrence rate, statistically significant improvement in immune parameters, enhanced antioxidant status, and superior quality-of-life outcomes compared to controls⁵,⁶,⁷,⁸.

Conclusion: Digitally supported Rasayana therapy represents a promising integrative oncology strategy for long-term cancer survivorship and recurrence prevention. Further randomized, multicentric trials are warranted⁹,¹⁰.